Intuitive Surgical, Inc. (ISRG) Rises Higher Than Market: Key Facts
Werte in diesem Artikel
Intuitive Surgical, Inc. (ISRG) ended the recent trading session at $534.38, demonstrating a +2.44% change from the preceding day's closing price. The stock exceeded the S&P 500, which registered a gain of 0.8% for the day. On the other hand, the Dow registered a gain of 0.94%, and the technology-centric Nasdaq increased by 0.97%. Prior to today's trading, shares of the company had lost 5.57% lagged the Medical sector's gain of 3.12% and the S&P 500's gain of 5.12%.Investors will be eagerly watching for the performance of Intuitive Surgical, Inc. in its upcoming earnings disclosure. The company is predicted to post an EPS of $1.92, indicating a 7.87% growth compared to the equivalent quarter last year. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $2.35 billion, up 16.81% from the year-ago period. ISRG's full-year Zacks Consensus Estimates are calling for earnings of $7.84 per share and revenue of $9.65 billion. These results would represent year-over-year changes of +6.81% and +15.56%, respectively. Any recent changes to analyst estimates for Intuitive Surgical, Inc. should also be noted by investors. These latest adjustments often mirror the shifting dynamics of short-term business patterns. As a result, we can interpret positive estimate revisions as a good sign for the business outlook. Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model. The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 0.02% higher. At present, Intuitive Surgical, Inc. boasts a Zacks Rank of #2 (Buy). From a valuation perspective, Intuitive Surgical, Inc. is currently exchanging hands at a Forward P/E ratio of 66.53. This valuation marks a premium compared to its industry average Forward P/E of 27.05. Investors should also note that ISRG has a PEG ratio of 4.4 right now. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. As the market closed yesterday, the Medical - Instruments industry was having an average PEG ratio of 2.25. The Medical - Instruments industry is part of the Medical sector. This group has a Zacks Industry Rank of 181, putting it in the bottom 27% of all 250+ industries. The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions. Don’t Miss Out on These Stocks Before you make your next investing move, we have a free report that highlights the %%CTA_TEXT%% to buy.Our experts at Zacks Investment Research hand-selected these stocks for their eye-opening growth projections.Since 1988, our stock picks have more than doubled the S&P 500 with an average gain of +23.89% per year using the Zacks Rank stock-rating system.Register now to see the %%CTA_TEXT%%.7 best stocksWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Intuitive Surgical, Inc. (ISRG): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: Intuitive Surgical und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.
Ausgewählte Hebelprodukte auf Intuitive Surgical
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Intuitive Surgical
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Intuitive Surgical Inc
Analysen zu Intuitive Surgical Inc
Datum | Rating | Analyst | |
---|---|---|---|
19.07.2019 | Intuitive Surgical Buy | Canaccord Adams | |
22.04.2019 | Intuitive Surgical Buy | Canaccord Adams | |
02.04.2019 | Intuitive Surgical Buy | Deutsche Bank AG | |
19.10.2018 | Intuitive Surgical Buy | Canaccord Adams | |
18.04.2018 | Intuitive Surgical Buy | Canaccord Adams |
Datum | Rating | Analyst | |
---|---|---|---|
19.07.2019 | Intuitive Surgical Buy | Canaccord Adams | |
22.04.2019 | Intuitive Surgical Buy | Canaccord Adams | |
02.04.2019 | Intuitive Surgical Buy | Deutsche Bank AG | |
19.10.2018 | Intuitive Surgical Buy | Canaccord Adams | |
18.04.2018 | Intuitive Surgical Buy | Canaccord Adams |
Datum | Rating | Analyst | |
---|---|---|---|
26.01.2018 | Intuitive Surgical Hold | Canaccord Adams | |
18.07.2017 | Intuitive Surgical Sector Perform | RBC Capital Markets | |
30.06.2017 | Intuitive Surgical Neutral | Cantor Fitzgerald | |
30.05.2017 | Intuitive Surgical Hold | Canaccord Adams | |
17.04.2017 | Intuitive Surgical Sector Perform | RBC Capital Markets |
Datum | Rating | Analyst | |
---|---|---|---|
23.01.2015 | Intuitive Surgical Sell | CRT Capital | |
22.10.2014 | Intuitive Surgical Sell | CRT Capital | |
09.01.2009 | Intuitive Surgical Downgrade | Brean Murray, Carret & Co., LLC | |
26.08.2005 | Update Intuitive Surgical Inc. : Underperform | Jefferies & Co |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Intuitive Surgical Inc nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen